A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels

Inclusion Criteria: * Documented diagnosis of recurrent kidney stone disease based on ≥2 stone events with a minimum of 1 stone event within 5 years prior to screening * Meets the 24 hour urine oxalate excretion requirements * The 2 most recently analyzed kidney stones prior to randomization contained 50% or more of calcium oxalate; if only one stone analysis is available, then it must have contained 50% or more of calcium oxalate Exclusion Criteria: * Known history of secondary causes of elevated urinary oxalate and/or recurrent kidney stones * Primary hyperoxaluria * Estimated glomerular filtration rate (eGFR) of \<30 mL/min/1.73m\^2 at screening * Received an investigational agent within the last 30 days or 5 half-lives, whichever is longer